Basal Ganglia Diseases Clinical Trial
Official title:
Recording of Gait and Speech Related Neurophysiological Parameters With an Implantable Bi-directional Deep Brain Stimulation System in Parkinson's Disease
Electrid activity of the basal ganglia will be recorded with an implantable deep brain
stimulation device (supplied by Medtronic Inc).
Study hypothesis is that these activities differ according to what the patient does, i.e.
are different during gait and speech.
Status | Recruiting |
Enrollment | 10 |
Est. completion date | December 2015 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 40 Years to 75 Years |
Eligibility |
Inclusion Criteria: - good levodopa response Exclusion Criteria: - dementia |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Germany | Dept. of Neurology, Ludwig-Maximilians University of Munich | Munich/München |
Lead Sponsor | Collaborator |
---|---|
Kai Bötzel | Lueneburg Heritage, Medtronic |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference of frequency spectrum of basal ganglia local field potentials during gait and speech | 1 year | No | |
Secondary | Evidence for the benefit of different stimulator settings for gait and speech | one year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04871464 -
Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
|
Phase 4 | |
Recruiting |
NCT02696603 -
Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
|
N/A | |
Recruiting |
NCT06193252 -
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
|
N/A | |
Recruiting |
NCT05452655 -
Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease
|
N/A | |
Recruiting |
NCT04985539 -
The Personalized Parkinson Project de Novo Cohort
|
||
Completed |
NCT01662414 -
Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease
|
Phase 4 |